A Phase II Open-Label Multi-Center Trial of Memantine (Namenda) Treatment of Pathological Gambling [gambling].

Trial Profile

A Phase II Open-Label Multi-Center Trial of Memantine (Namenda) Treatment of Pathological Gambling [gambling].

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Apr 2013

At a glance

  • Drugs Memantine (Primary)
  • Indications Gambling
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Feb 2012 Actual patients number is 29 as reported by ClinicalTrials.gov.
    • 23 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Apr 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top